1. Home
  2. LQDT vs GERN Comparison

LQDT vs GERN Comparison

Compare LQDT & GERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Liquidity Services Inc.

LQDT

Liquidity Services Inc.

HOLD

Current Price

$31.40

Market Cap

985.8M

ML Signal

HOLD

Logo Geron Corporation

GERN

Geron Corporation

HOLD

Current Price

$1.77

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LQDT
GERN
Founded
1999
1990
Country
United States
United States
Employees
N/A
229
Industry
Catalog/Specialty Distribution
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
985.8M
1.1B
IPO Year
2005
N/A

Fundamental Metrics

Financial Performance
Metric
LQDT
GERN
Price
$31.40
$1.77
Analyst Decision
Buy
Hold
Analyst Count
1
3
Target Price
$40.00
$2.17
AVG Volume (30 Days)
132.5K
18.3M
Earning Date
05-07-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
38.10
N/A
EPS
0.23
N/A
Revenue
$476,669,000.00
N/A
Revenue This Year
N/A
$26.91
Revenue Next Year
N/A
$43.75
P/E Ratio
$136.26
N/A
Revenue Growth
31.20
N/A
52 Week Low
$21.67
$1.04
52 Week High
$33.61
$2.01

Technical Indicators

Market Signals
Indicator
LQDT
GERN
Relative Strength Index (RSI) 59.15 60.87
Support Level $30.51 $1.24
Resistance Level $32.58 $2.01
Average True Range (ATR) 0.84 0.10
MACD 0.30 0.03
Stochastic Oscillator 93.18 83.71

Price Performance

Historical Comparison
LQDT
GERN

About LQDT Liquidity Services Inc.

Liquidity Services Inc is an online auction marketplace. It manages and sells inventory and equipment for business and government clients by operating a network of e-commerce marketplaces that enable buyers and sellers to transact in an efficient, automated environment offering across different product categories. The company has four reportable segments: GovDeals, Retail Supply Chain Group (RSCG), and Machinio & Software Solutions. It generates majority of its revenue from Retail Supply Chain Group (RSCG) segment which consists of marketplaces that enable corporations located in the United States and Canada to sell excess, returned, and overstocked consumer goods. Geographically, a substantial portion the company's revenue is generated from its business in United States.

About GERN Geron Corporation

Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.

Share on Social Networks: